Aslani, Nikka M.

HRN: 21-81-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
MUPIROCIN 2%, 15G (TUBE)
08/31/2025
09/06/2025
TOPICAL
Squirt
BID
7days
Checking Initial Appropriateness 
08/31/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2025
09/06/2025
IVT
120mg
Q6
Skin Infection
Checking Initial Appropriateness 
09/01/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/01/2025
09/08/2025
PO
5ml
TID
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: